Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

445 results about "Oocyte" patented technology

An oocyte (UK: /ˈoʊəsaɪt/, US: /ˈoʊoʊ-/), oöcyte, ovocyte, or rarely ocyte, is a female gametocyte or germ cell involved in reproduction. In other words, it is an immature ovum, or egg cell. An oocyte is produced in the ovary during female gametogenesis. The female germ cells produce a primordial germ cell (PGC), which then undergoes mitosis, forming oogonia. During oogenesis, the oogonia become primary oocytes. An oocyte is a form of genetic material that can be collected for cryoconservation. Cryoconservation of animal genetic resources has been put into action as a means of conserving traditional livestock.

Cherax quadricarinatus oocyte targeted penetrating peptide VgSP and in-vivo delivery method thereof

The invention discloses a cherax quadricarinatus oocyte targeted penetrating peptide VgSP and a living body delivery method thereof, and belongs to the technical field of biology. The invention provides the cherax quadricarinatus oocyte targeted penetrating peptide VgSP on one hand, and provides application of the cherax quadricarinatus oocyte targeted penetrating peptide VgSP on the other hand. The invention provides a polypeptide VgSP capable of being recognized by a cherax quadricarinatus oocyte surface receptor and mediated into an oocyte, and an injection and detection method of the polypeptide in sub-adult and adult female cherax quadricarinatus. The breakthrough lays a technical foundation for establishing a gene editing element delivery method with oocyte targeting, and is expected to be applied to the field of cherax quadricarinatus gene editing.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES

Easy-to-operate automatic flushing structure and oocyte acquisition device

Provided is an ease-to-operate automatic flushing structure, comprising a mounting housing (2), an injector driving mechanism, and an injector clamping mechanism. The mounting housing (2) is a structure with a clamping groove on a side portion thereof, and the injector clamping mechanism is arranged on an outer side of the clamping groove. The injector driving mechanism is arranged in the mounting housing (2). Also provided is an oocyte acquisition device, comprising an acquisition device body. An automatic flushing structure is arranged on a side portion of the acquisition device body.
Owner:TONGYE TECH DEV

Micro-fluidic chip for vitrification cryopreservation of oocytes or embryos as well as preparation method and application of micro-fluidic chip

ActiveCN119096971AReduce Toxic DamageReduce osmotic pressure shockBioreactor/fermenter combinationsBiological substance pretreatmentsEngineeringCryopreservation
The invention discloses a micro-fluidic chip for vitrification cryopreservation of oocytes or embryos and a preparation method and application of the micro-fluidic chip. The micro-fluidic chip comprises a micro-fluid channel layer, and the micro-fluid channel layer is arranged in the micro-fluid flowing direction; the microfluid channel layer comprises one or more solution inflow channels, a snakelike mixing channel, one or more shunt channels, a snakelike channel, a cell storage chamber and a waste liquid discharge channel which are communicated in sequence; wherein a first micro-column array is arranged at an outlet of the cell storage chamber, and a second micro-column array is arranged in a channel outside an inlet of the cell storage chamber; and a cell channel is communicated between the cell storage chamber and the second micro-column array. The micro-fluidic chip can realize the integration of operations such as vitrification cryopreservation and rewarming, reduces the cell transfer frequency, avoids pollution, improves the treatment efficiency, can significantly improve the survival rate of oocytes or embryos after rewarming, and can further promote the development of an assisted reproduction technology.
Owner:ANHUI MEDICAL UNIV

Application of urolithin A in preparation of medicine or health food for delaying ovarian senescence

The invention belongs to the technical field of biological medicines, and discloses application of urolithin A in preparation of medicines or health-care foods for delaying ovarian aging. The invention proves that by supplementing urolithin A, the fertility of the senescent ovary can be improved, the estrus cycle of the senescent ovary can be shortened, the fibrosis level of a senescent ovary matrix can be reduced, the ovary reserve capacity can be improved, the quality of a senescent ovary oocyte can be improved, and the fertilization and embryonic development potential can be improved; it is proved that urolithin A can be used as an effective component for preparing the medicine or health food for delaying ovarian aging.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV

Application of MY-1B in preparation of medicine for improving ovarian aging

The invention discloses application of MY-1B in preparation of medicines for improving ovarian aging, belongs to the technical field of biological medicines, and aims to solve the problems of how to effectively delay ovarian aging and improve ovarian functions. Experiments prove that the mRNA m5C modification level of ovarian granular cells in the ovarian aging process is increased, and the expression level of methylated transferase Nsun2 is increased. Ovarian aging caused by mRNA m5C modification level increase can be improved by supplementing the MY-1B, which is embodied in that the MY-1B can reduce the mRNA m5C modification level of aging nest granular cells; the MY-1B can be used for effectively correcting the orbital cycle disorder of the aged ovary and delaying the decline of the ovarian function; the MY-1B plays an important role in reducing the apoptosis level of granulosa cells in senescent ovaries; the MY-1B can improve the storage capacity of ovaries and enhance the quality of oocytes, so that the fertilization rate and the embryonic development potential of the oocytes are improved.
Owner:INST OF ZOOLOGY CHINESE ACAD OF SCI

Method implemented by computer system and oocyte mass analysis system

The present disclosure relates generally to systems and methods for assessing oocyte viability. In some embodiments, a sequence of images associated with an oocyte sucked into a pressure tool is acquired. Based on the sequence of images and the pressure applied to the oocytes, morphological and mechanical features associated with the oocytes can be derived. At least some of the features may then be provided to a machine learning model to determine an indicator representative of oocyte quality, where a particular indicator may be representative of blastocyst formation. Optionally, the determined oocyte quality information may be presented to a user via an interactive user interface.
Owner:INTI TAIWAN INC

Traditional Chinese medicine composition for repairing and / or activating residual ovarian function of senescence ovary and preparation method and application thereof

The invention discloses a traditional Chinese medicine composition for repairing and / or activating residual ovarian functions of an aging ovary, and a preparation method and application thereof, and relates to the technical field of biology. The traditional Chinese medicine composition is prepared from the following components: radix astragali, radix angelicae sinensis, radix ophiopogonis, radix polygonati officinalis, semen cuscutae, radix morindae officinalis, fructus rubi, rhizoma dioscoreae and folium mori. The invention further provides application of the traditional Chinese medicine composition in repairing and / or activating the residual ovarian function of the senescent ovary and improving the quality of the senescent oocyte, the traditional Chinese medicine composition can increase the volume and weight of the senescent ovary, increase the number of follicles of all levels in the senescent ovary, reduce apoptosis of granular cells in the ovary and improve the survival rate of the senescent ovary. The abnormal rate of oocytes, oxidative stress of the oocytes and DNA damage are reduced, development and maturation of residual follicles are promoted and maintained, and the traditional Chinese medicine composition has a wide application prospect.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Compositions and methods for treating ovarian aging, ovarian diseases and conditions, and symptoms thereof

Methods of enhancing or improving fertility are disclosed. Methods of extending reproductive longevity are disclosed. Methods of increasing oocyte mitochondrial mass or preventing a decrease of oocyte mitochondrial mass are disclosed. Methods of improving embryo development or improving embryo fertilization rate are disclosed. Methods of treating or preventing an ovarian disease or condition are disclosed. Methods of reducing, preventing, or delaying perimenopause, menopause, or a symptom thereof are disclosed. The methods include administering an Emblica extract or a compound constituent of or having a similarity score of at least 95% with a compound constituent of an Emblica extract, or Fucus extract or a compound constituent of or having a similarity score of at least 95% with a compound constituent of a Fucus extract, or a chebula extract or a compound constituent of or having a similarity score of at least 95% with a compound constituent of a chebula extract.
Owner:YUVA BIOSCIENCES INC

Optical Coherence Tomography in an Intelligent Automated In Vitro Fertilization and Intracytoplasmic Sperm Injection Platform

A method for automated, artificial-intelligence-based egg identification using optical coherence tomography (OCT) includes positioning an OCT imaging system head in proximity to a biological sample containing an oocyte, wherein the OCT is operatively coupled to an artificial intelligence / machine learning system (AI / ML system) and an imaging system, wherein the imaging system includes a camera system, and a lighting system. The method includes creating at least one three-dimensional image of the oocyte using the OCT, AI / ML system, and imaging system. The method includes using the AI / ML system to analyze the three-dimensional image, wherein an analysis includes detection of a polar body's presence or absence based at least in part on planar views of the oocyte.
Owner:CONCEIVABLE LIFE SCI INC

Ovary-targeting ROS (reactive oxygen species) response type SS31 nano-particles as well as preparation method and application thereof

The invention provides an ovary-targeting ROS response type SS31 nano-particle and a preparation method and application thereof, and belongs to the field of biomedicine.The ovary-targeting ROS response type SS31 nano-particle is constructed by utilizing a porous metal organic framework to carry hyaluronic acid and utilizing an ROS response type thioketone linker to be combined with mitochondrial targeting peptide SS31, and the ovary-targeting ROS response type SS31 nano-particle is used for preparing the ovary-targeting ROS response type SS31 nano-particle. And the SS31 is targeted and delivered to the ovarian tissue. The nanoparticles target ovary and slowly release SS31 under the action of ROS, so that oxidative stress of oocytes and granular cells caused by female reproductive system diseases such as premature ovarian failure, polycystic ovarian syndrome and the like is reduced, and the mitochondrial function of the oocytes and the granular cells is improved; and a foundation is laid for the subsequent clinical treatment of diseases related to the mitochondrial dysfunction of the female reproductive system by using the SS31.
Owner:SICHUAN PROVINCIAL HOSPITAL FOR WOMEN & CHILDREN

Oocyte collector

The oocyte collector comprises a collecting cylinder, a piston is slidably connected to the interior of the collecting cylinder, a sliding rod is fixedly connected to the side wall of the piston and penetrates through the side wall of one end of the collecting cylinder, and a push plate is fixedly connected to the end, extending out of the collecting cylinder, of the sliding rod; an egg taking needle is fixedly connected to the side wall of the piston, the end, close to the egg taking needle, of the collecting cylinder is hemispherical and provided with a through hole, the through hole and the axis of the egg taking needle are collinear, a pressure sensor is arranged on the outer side wall of the egg taking needle, and a temperature sensor and a vibration sensor are arranged on the outer side wall, close to the through hole, of the collecting cylinder; the side wall of the egg taking needle is fixedly connected with a first connecting pipe. According to the ovary internal hydraulic pressure, the ovary side wall temperature and the ovary side wall fluctuation frequency, the air suction power of the air suction pump can be dynamically regulated and controlled, then the oocyte collection quality is improved, and ovary damage is reduced.
Owner:HEILONGJIANG ACAD OF AGRI SCI ANIMAL HUSBANDRY & VETERINARY BRANCH

Procambarus clarkii egg cell guide peptide, fusion protein, nucleic acid molecule, recombinant expression vector, host cell, method for guiding foreign protein to enter procambarus clarkii egg cells and application of procambarus clarkii egg cell guide peptide

The invention relates to the fields of molecular biology and genetic engineering, and relates to a cherax quadricarinatus egg cell guide peptide, a fusion protein, a nucleic acid molecule, a recombinant expression vector, a host cell, a method for guiding a foreign protein to enter a cherax quadricarinatus egg cell and application of the cherax quadricarinatus egg cell guide peptide. The amino acid sequence of the cambarus clarkii egg cell guide peptide is as shown in SEQ ID NO. 1. According to the invention, green fluorescent protein (eGFP) is used as example protein, which proves that the polypeptide can successfully deliver foreign protein. The breakthrough can lay a technical foundation for introducing a gene editing tool (such as a CRISPR-Cas9 system) into a crayfish oocyte, and is expected to be widely applied to the fields of crayfish breeding, functional gene research, aquaculture gene improvement and the like.
Owner:SHANDONG UNIV

Application of CTH inhibitor and / or xCT inhibitor in preparation of medicine for inhibiting mammalian embryo implantation

The invention provides an application of a CTH inhibitor and / or an xCT inhibitor in preparation of a medicine for inhibiting mammal embryo implantation, and relates to the technical field of medicines. The application effect of a cystathionine-gamma-lyase (CTH) inhibitor and / or a solute carrier family 7 member 11 (xCT) inhibitor in inhibition of mammalian embryo implantation is verified through research. The research result shows that the xCT inhibitor and / or the CTH inhibitor can obviously inhibit proliferation of corpus luteinized granular cells and secretion of progesterone of a model mouse; meanwhile, by injecting the xCT inhibitor and / or the CTH inhibitor into the mouse model in vivo, ovary ovulation and the maturation rate of the ovulated oocyte nucleus can be remarkably inhibited, functional corpus luteum formation and embryo implantation can be remarkably reduced, and then a new thought and method are provided for development of contraceptive drugs.
Owner:INST OF SPECIAL ANIMAL & PLANT SCI OF CAAS

Predicting embryo ploidy status using time-lapse images

The present disclosure encompasses systems and methods for predicting embryo ploidy. Specific embodiments encompass methods of non-invasively predicting ploidy status of an embryo, by receiving a dataset with video including a plurality of image frames of the embryo, analyzing the plurality of image frames by one or more machine and / or deep learning model via one or more classification task applied to the dataset; and generating an output prediction of the ploidy status of the embryo. Particular methods relate to methods wherein the dataset additionally includes one or more clinical and / or morphological features for the embryo, such as maternal age at the time of oocyte retrieval. Embodiments also relate to predicting embryo viability and / or improving embryo selection, such as during in vitro fertilization, and uses thereof.
Owner:CORNELL UNIVERSITY

Automatic liquid flushing structure convenient to operate and oocyte collecting instrument

ActiveCN222130225Ureduce usageAvoid the inconvenience of disinfection and sterilizationEnemata/irrigatorsObstetrical instrumentsPeristaltic pumpApparatus instruments
The utility model belongs to the field of medical instruments, and relates to an automatic liquid flushing structure convenient to operate, which comprises a mounting shell, an injector driving mechanism and an injector clamping mechanism, the side part of the mounting shell is provided with a clamping groove, the injector clamping mechanism is arranged on the outer side of the clamping groove, and the injector driving mechanism is arranged in the mounting shell. The utility model further relates to an oocyte collecting instrument, and an automatic liquid flushing structure is arranged on the side portion of the collecting instrument body. The liquid injection device is convenient to operate, high in liquid amount precision and stable in flow speed, saves labor, reduces use of pump pipe consumables indispensable in a peristaltic pump liquid injection mode, and meanwhile avoids the problem that the pump pipe is inconvenient to disinfect and sterilize.
Owner:TONGYE TECH DEV

Micro-fluidic chip structure for oocyte separation and collection

The utility model discloses a micro-fluidic chip structure for oocyte separation and collection, which comprises a shell, a first separation bin and a second separation bin are respectively arranged at two ends in the shell, and the first separation bin is communicated with the second separation bin; the first separation bin is externally communicated with an inlet, and the second separation bin is externally communicated with a recovery port; a first channel is arranged in the first separation bin, and first capturing pits are arrayed at the bottom of the first channel; the second separation bin internally comprises a second channel, and channel columns are arranged in the second channel in an array mode; according to the utility model, a culture solution can be directly injected into the shell from the inlet and can be recycled for repeated separation, so that the content of obtained cells is high, the separation is convenient and rapid, and the manpower is greatly saved.
Owner:ANHUI MEDICAL UNIV

Oocyte generation and maturation disorder detection panel, detection kit and application thereof

The invention relates to the technical field of assisted reproduction polygene detection, and discloses an oocyte occurrence and maturation disorder detection panel, a detection kit and application thereof, and the detection panel comprises mutation genes related to the oocyte occurrence and maturation disorder for detection, copy number variation genes and rearrangement event and deletion genes. According to the application, by detecting high-risk genes and mutation sites, the risk of occurrence and maturation disorder of the oocytes is predicted in combination with clinic, the development potential of the oocytes is evaluated, the in-vitro maturation strategy is optimized, and the clinical outcome of assisted reproduction is improved. The detection panel can be used for efficiently detecting gene mutation which has clinical diagnosis and treatment significance on oocyte occurrence and maturation disorders; the method has important guiding significance on genetic counseling, risk prediction, clinical diagnosis, precise treatment and potential personalized intervention measures of patients suffering from recurrent oocyte occurrence disorder, oocyte maturation disorder and low oocyte maturation rate and patients to be subjected to assisted reproduction technology treatment.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

SiRNA for improving developmental capacity of cryopreserved oocytes and application thereof

The invention discloses siRNA for improving the developmental capacity of cryopreserved oocytes and application of the siRNA, belongs to the technical field of cryopreservation of the oocytes, and provides siRNA molecules for improving the developmental capacity of the cryopreserved oocytes. Nucleotide sequences of the siRNA molecules are shown as SEQ ID NO.1 and SEQ ID NO.2; the invention also provides an application of the siRNA molecule in preparation of a preparation for improving the developmental capacity of cryopreserved oocytes. The siRNA for targeted inhibition of Atf5 gene expression is provided, the siRNA is microinjected into oocyte cytoplasm, target gene mRNA expression can be specifically silenced, the Atf5 gene expression quantity is significantly reduced, the mitochondrial function under freezing stress is maintained, and the developmental capacity of frozen oocytes is improved.
Owner:CHINA AGRI UNIV +1

Application of MY-1B in the preparation of drugs for improving ovarian senescence

The present invention discloses the application of MY-1B in the preparation of drugs for improving ovarian senescence, belonging to the technical field of biomedicine, aiming to solve the problem of how to effectively delay ovarian senescence and improve ovarian function. Experiments have proved that during ovarian senescence, the mRNA m<supgt;5< / supgt;C modification level and the expression level of methyltransferase in ovarian granulosa cells increase. Supplementation with MY-1B can improve the condition caused by mRNA m Nsun2 expression.
Owner:INST OF ZOOLOGY CHINESE ACAD OF SCI

Apparatus and method for oocyte rescue in vitro post stimulation

PendingUS20240418370A1Continuous combustion chamberPump componentsBiotechnologyIn vitro stimulation
An apparatus and method for oocyte rescue in vitro post stimulation, the apparatus including a computing device, wherein the computing device includes at least a processor; and a memory communicatively connected to the at least processor, the memory containing instructions configuring the at least processor to: receive biological sample data from a biological sample relating to a user, including at least an oocyte; determine a maturity level of the at least an oocyte; assign the at least an oocyte to a culture protocol as a function of the maturity level; receive culture data relating to the at least an oocyte as a function of the culture protocol; and calculate a scoring metric as a function of the culture data.
Owner:GAMETO INC

Method and apparatus for categorising fish oocytes

A method of analysing a sample of a plurality of fish oocytes (100) is disclosed The method comprises, for each oocyte in the sample: capturing a first set of images of the oocyte from a plurality of rotational angels when rotated about a first axis of rotation; capturing a second set of images of the oocyte from a plurality of rotational angels when rotated about a second axis of rotation, which second axis of rotation is orthogonal to the first axis of rotation; identifying at least one characteristic (104) of lipid droplet coalescence in the captured first and second sets of images; and based on the identified at least one characteristic of lipid droplet coalescence, classifying the oocyte as belonging to one of a plurality of predefined categories, and based on the distribution of the sampled oocytes in the plurality of categories, attributing a quality parameter to the sample of oocytes, the quality parameter being any one of: a predicted fertilisation rate of the sampled oocytes; a predicted eyed-embryo success rate of the sampled oocytes; and a predicted hatching success rate of the sampled oocytes. A computer-implemented method of attributing a quality measure to a sample of fish oocytes is also disclosed, as is a related computer program and a related oocyte analysis apparatus. A computer-implemented method for training a neural network for use in a system for analysing a sample of fish oocytes is also disclosed.
Owner:CRYOGENETICS

Method for electrically activating oocyte based on nanosecond pulse

The invention relates to a method for electrically activating oocytes based on nanosecond pulses. Single oocytes are sequentially and uniformly arranged between two parallel electrodes of an electrode dish, the electrode dish is characterized in that the distance between the electrodes is 1 mm, the electrodes are placed in a culture dish, and the two ends of the two electrodes are sealed; a culture solution is firstly put between the electrodes which are arranged in parallel, mineral oil is covered to prevent the culture solution from being evaporated, after preheating treatment, oocytes are sequentially and uniformly put between the two electrodes which are arranged in parallel one by one, and then nanosecond pulse electric activation treatment is applied. The electrodes which are arranged in parallel are adopted, the oocytes are sequentially and uniformly placed between the electrodes in a single mode, the situation that the electric pulse effect is reduced due to adhesion and stacking of all the cells is avoided, the oocytes receive uniform and equivalent electric pulse sequences, the action effect and stability of electric pulses on the cells are obviously improved, and the operation efficiency of the oocytes is improved. And the reliability and reproducibility of a test conclusion are improved.
Owner:CHINA AGRI UNIV

Method for realizing target gene editing of prawn offspring by exopalaemon carinicauda or vannabine

The invention relates to a method for editing target genes of prawn filial generations by exopalaemon carinicauda or vannabine and application of the method. Based on the gonad development and reproduction characteristics of shrimps and crabs, Cas9 RNP (a mixture formed by mixing sgRNA and Cas9 ribonucleoprotein) is directly injected into bodies of exopalaemon carinicauda or litopenaeus vannamei with developed ovaries in an intramuscular injection manner. The used sgRNA is a guide RNA (Ribonucleic Acid), namely EcIAG-gRNA or LvIAG-gRNA, which is designed on the basis of an IAG gene (EcIAG or LvIAG) of exopalaemon carinicauda or litopenaeus vannamei. Different gRNAs and Cas9 proteins are respectively mixed and then injected into an exopalaemon carinicauda or litopenaeus vannamei parent body through intramuscular injection, Cas9 RNP can enter an ovary along with blood circulation and enter an oocyte along with development of the ovary, editing of a target gene on a genome is realized, and after the edited oocyte develops into an ovum, a progeny edited mutant is formed through fertilization. The method can also be used for delivering other biological macromolecular substances to oocytes of decapod crustacean such as exopalaemon carinicauda or litopenaeus vannamei.
Owner:INST OF OCEANOLOGY - CHINESE ACAD OF SCI

Application of rapamycin combined vascular endothelial growth factor A in preparation of medicine for improving ovarian tissue function

The invention discloses application of rapamycin combined with a vascular endothelial growth factor A in improvement of an ovarian tissue function. The improvement of the ovarian tissue function comprises any one or more than two of the following aspects: increasing the survival rate of follicles, prolonging the functional life of the ovarian tissue and improving the quality of oocytes. The effective concentration of the rapamycin is 500nM, and the effective concentration of the vascular endothelial growth factor A is 5ng / mL. The follicle loss dynamic after OTCT is tracked through a mouse model, it is found that rapid follicle loss is related to tip cell damage and primordial follicle activation, then a rapamycin and vascular endothelial growth factor A combination strategy is provided, follicle loss can be remarkably reduced, the reproductive function period can be prolonged, and the oocyte quality can be improved; according to the invention, a systematic solution is provided for OTCT technology optimization.
Owner:SHANDONG UNIV +1

Application of ACSL4 inhibitor in preparation of medicine for improving quality reduction of elderly ovum

The invention discloses application of an ACSL4 inhibitor in preparation of a medicine for improving quality reduction of an elderly ovum, and belongs to the technical field of biological medicines. The invention provides an application of targeting long-chain fatty acid acyl-coenzyme A synthetase 4 (ACSL4) in intervention of low oocyte quality and related fertility decline caused by aging. The ACSL4 inhibitor can be used for preparing drugs for improving ovarian functions and improving oocyte quality. In-vivo and in-vitro experiments prove that by inhibiting the ACSL4, the aging process of the elderly ovary can be effectively relieved, the expression of aging-related proteins p16 and p21 can be reduced, the mitochondrial function of the oocyte can be improved, and spindle assembly abnormality and chromosome arrangement defects can be rescued, so that the maturation rate and the development potential of the oocyte can be remarkably improved.
Owner:SOUTHEAST UNIV

Bovine oocyte in-vitro maturation culture solution as well as preparation method and application thereof

PendingCN121379939AGerm cellsBiotechnologyBovine oocyte
The invention discloses a bovine oocyte in-vitro maturation culture solution as well as a preparation method and application thereof, and belongs to the technical field of animal reproduction and embryo engineering. The preparation method of the bovine oocyte in-vitro maturation culture solution comprises the step of adding mitoquinine mesylate into a conventional IVM culture solution, wherein the adding concentration of the mitoquinine mesylate is preferably 50 nmol / L. The bovine oocyte in-vitro maturation culture solution provided by the invention can effectively reduce the oxidative stress reaction of the oocytes in the in-vitro culture process, enhance the mitochondrial function and remarkably improve the bovine oocyte in-vitro maturation quality and the embryonic development potential, so that the blastocyst rate is increased, and the problem that the development potential of the existing oocyte IVM culture solution is insufficient is solved.
Owner:JILIN ACAD OF AGRI SCI

Method for reducing lipid content of oocytes or improving freezing survival rate of oocytes

The invention discloses a method for reducing the lipid content of an oocyte or increasing the freezing survival rate of the oocyte. The method comprises the following steps: (1) preheating an incubation solution; incubating the oocytes in the preheated incubation liquid; (2) freezing and unfreezing the incubated oocytes; wherein the incubation liquid is prepared by adding bezafibrate and cholic acid into a culture medium 199 containing 10wt% of fetal calf serum. Compared with a conventional culture medium 199 containing 10 wt% of fetal calf serum, the incubation liquid used in the method provided by the invention has the advantages that bezafibrate and cholic acid which are added have a synergistic lipid-lowering effect, so that the lipid content of the oocytes can be remarkably reduced or the freezing survival rate of the oocytes can be increased by the method. The method has application prospects in the aspects of reducing the lipid content of the oocytes or improving the freezing survival rate of the oocytes and the like.
Owner:SHANGHAI ACAD OF AGRI SCI

A biological agent for reducing oxidative damage of bovine oocytes

The present invention provides a biological preparation for reducing oxidative damage to bovine oocytes, and belongs to the field of animal breeding technology. Specifically, the present invention applies the antimicrobial peptide KR-12amide to the technical field of bovine oocyte maturation and oxidative damage. The present invention finds that the antimicrobial peptide KR-12amide can effectively reduce the oxidative damage of bovine oocytes and improve the maturation ability and maturation quality of bovine oocytes, which expands the application scope of the antimicrobial peptide KR-12amide, and the polypeptide drug has the advantages of strong stability and few side effects, and is safer and more effective in the application of bovine oocyte breeding.
Owner:QINGDAO PUXING BIO TECH CO LTD

Synchronous oestrus-timed insemination method suitable for cows

The invention relates to the technical field of animal husbandry, in particular to a synchronous oestrus-timing insemination method suitable for cattle, which comprises the following steps: firstly, performing intramuscular injection of PG (cloprostenol sodium) at different time points after calving to promote uterine recovery and luteolysis and lay a synchronous oestrus foundation; the method comprises the key steps that GnRH (gonadotropin release hormone) is given through intramuscular injection on the 43rd day, the 53rd day, the 60th day and the 69th day, pituitary is promoted to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), collection and screening of follicles are guided, follicle maturation is promoted, the oestrus uncovering rate and the oestrus conception rate are increased, a melatonin implant is implanted in a subcutaneous implantation mode on the 63rd day, and the melatonin implant is implanted in a subcutaneous implantation mode on the 63rd day. The synthesis of ovarian hormones is promoted by regulating the hypothalamus-pituitary-gonad axis, the secretion of follicle cell factors and maturation promoting factors is promoted, the development of granular cells is promoted, and the maturation of oocytes is promoted. According to the method, the pregnancy rate of a double-synchronization-timing insemination scheme which is most widely used in a large-scale dairy cow breeding pasture at present can be remarkably increased, and feasible technical support is provided for success of increasing the breeding efficiency of cows.
Owner:张靖

SiRNA for schistosoma japonicum hsc20 gene expression and application thereof

This invention relates to the fields of molecular biology and biomedicine, and discloses siRNA for the expression of the *Schistosoma japonicum* Hsc20 gene and its applications. The siRNA contains a nucleotide sequence that hybridizes to a target sequence of the *Schistosoma japonicum* Hsc20 gene, wherein the target sequence is selected from the sequences shown in SEQ ID NO. 1-SEQ ID NO. 4. The siRNA specifically inhibiting the expression of the *Schistosoma japonicum* Hsc20 gene provided by this invention can be used to interfere with the transcription and expression of the *Schistosoma japonicum* Hsc20 gene and the growth and development of *Schistosoma japonicum*. In vitro experiments have confirmed that the siRNA provided by this invention can efficiently silence the *SjHsc20* gene; and in vivo RNA interference experiments in mice show that this siRNA can induce 50.62% (…) P The insect reduction rate was <0.05% and 44.29% ( P A liver oocyte reduction rate of <0.01% is suitable for preparing drugs to treat schistosomiasis.
Owner:FOSHAN UNIVERSITY